Mortality trends in patients hospitalized with the initial acute myocardial infarction in a Middle Eastern country over 20 years

Cardiology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Ahmed, Emad ^a,b   Al Suwaidi, Jassim ^a   El Menyar, Ayman ^c,d,e   Albinali, Hajar A H ^a   Singh, Rajvir ^a   Gehani, A A ^a,c  

^a Heart Hospital   (Qatar)

^b NATIONAL HEART INSTITUTE   (Egypt)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^d HAMAD MEDICAL CORPORATION   (Qatar)

^e Ahmed Maher Teaching Hospital   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY REPERFUSION; DRUG USE; DRUG UTILIZATION; ETHNICITY; EVIDENCE BASED MEDICINE; FEMALE; FIBRINOLYTIC THERAPY; HEART ARREST; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RESUSCITATION; SEX DIFFERENCE; SMOKING; TREND STUDY;

EID: 84901248090     PISSN: 20908016     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2014/464323     Document Type: Article

References (46)

1. WHO, World Health Statistics 2008 2008 Geneva, Switzerland World Health Organization. http://www.who.int/whosis/whostat/EN-WHS08 -Full.pdf
2. Braunwald E., Antman E. M., Beasley J. W., Cheitlin M. D., Hochman J. S., Jones R. H., Kereiakes D., Kupersmith J., Levin T. N., Pepine C. J., Schaeffer J. W., Smith E. E. III, Steward D. E., Theroux P., Gibbons R. J., Antman E. M., Alpert J. S., Faxon D. P., Fuster V., Gregoratos G., Hiratzka L. F., Jacobs A. K., Smith S. C. Jr., ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2002 40 7 1366 1374 2-s2.0-0037010012 10.1016/S0735-1097(02)02336-7
3. Antman E. M., Anbe D. T., Armstrong P. W., American College of Cardiology, American Heart Association Task Force on Practice Guidelines, Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004 110 9 e82 e292
4. Ryan T. J., Antman E. M., Brooks N. H., Califf R. M., Hillis L. D., Hiratzka L. F., Rapaport E., Riegel B., Russell R. O., Smith E. E. III, Weaver W. D., Gibbons R. J., Alpert J. S., Eagle K. A., Gardner T. J., Garson A. J., Gregoratos G., Russell R. O., Ryan T. J., Smith S.C. J., 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Journal of the American College of Cardiology 1999 34 3 890 911 2-s2.0-0033621148 (Pubitemid 29436200)
5. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G., Heart outcomes prevention evaluation study investigators. Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high risk patients. The New England Journal of Medicine 2000 342 3 145 153 10.1056/NEJM200001203420301 (Pubitemid 30051645)
6. Instituto Nacional de Estadística, Defunciones según la causa de muerte 2006. http://www.ine.es
7. Murray C. J. L., Lopez A. D., Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. The Lancet 1997 349 9064 1498 1504 2-s2.0-0031001720 10.1016/S0140-6736(96)07492-2 (Pubitemid 27216360)
8. Tunstall-Pedoe H., Kuulasmaa K., Mähönen M., Tolonen H., Ruokokoski E., Amouyel P., Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. The Lancet 1999 353 9164 1547 1557 2-s2.0-0033535812 10.1016/S0140-6736(99)04021-0 (Pubitemid 29219203)
9. Gil M., Martí H., Elosúa R., Grau M., Sala J., Masiá R., Pérez G., Roset P., Bielsa O., Vila J., Marrugat J., Analysis of trends in myocardial infarction case-fatality, incidence and mortality rates in Girona, Spain, 1990-1999. Revista Espanola de Cardiologia 2007 60 4 349 356 2-s2.0-34249983134 10.1157/13101638 (Pubitemid 46881540)
10. van de Werf F., Ardissino D., Betriu A., Chair C., Cokkinos D. V., Falk E., Fox K. A. A., Julian D., Lengyel M., Neumann F.-J., Ruzyllo W., Thygesen C., Underwood S. R., Vahanian A., Verheugt F. W. A., Wijns W., Management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal 2003 24 1 28 66 2-s2.0-0037232464 10.1016/S0195-668X(02)00618-8 (Pubitemid 36109547)
11. Kushner F. G., Hand M., Smith S. C. Jr., 2009 Focused updates: ACC/AHA guidelines for the management of patients with st-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC, (AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). Journal of the American College of Cardiology 2009 54 2205 2241 10.1016/j.jacc.2009.10.015
12. Kalla K., Christ G., Karnik R., Malzer R., Norman G., Prachar H., Schreiber W., Unger G., Glogar H. D., Kaff A., Laggner A. N., Maurer G., Mlczoch J., Slany J., Weber H. S., Huber K., Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI Registry). Circulation 2006 113 20 2398 2405 2-s2.0-33744457665 10.1161/CIRCULATIONAHA.105.586198 (Pubitemid 43948047)
13. Ford E. S., Ajani U. A., Croft J. B., Critchley J. A., Labarthe D. R., Kottke T. E., Giles W. H., Capewell S., Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. The New England Journal of Medicine 2007 356 23 2388 2398 2-s2.0-34250019702 10.1056/NEJMsa053935 (Pubitemid 46883773)
14. Hardoon S. L., Whincup P. H., Lennon L. T., Wannamethee S. G., Capewell S., Richard W. Morris R. W. M., How much of the recent decline in the incidence of myocardial infarction in british men can be explained by changes in cardiovascular risk factors? evidence from a prospective population-based study. Circulation 2008 117 5 598 604 2-s2.0-40149099633 10.1161/CIRCULATIONAHA.107. 705947
15. Al Suwaidi J., Al-Qahtani A., Asaad N., Al-Mulla A. W., Singh R., Albinali H. A., Comparison of women versus men hospitalized with heart failure (from a 20-year registry in a Middle-Eastern country 1991-2010). American Journal of Cardiology 2012 109 3 395 400 2-s2.0-84855953831 10.1016/j.amjcard. 2011.09.026
16. Al Suwaidi J., Bener A., Hajar H. A., Numan M. T., Does hospitalization for congestive heart failure occur more frequently in Ramadan: apopulation-based study (1991-2001). International Journal of Cardiology 2004 96 2 217 221 2-s2.0-3242805246 10.1016/j.ijcard.2003.06.018 (Pubitemid 38979901)
17. Masoudi F. A., Foody J. M., Havranek E. P., Wang Y., Radford M. J., Allman R. M., Gold J., Wiblin R. T., Krumholz H. M., Trends in acute myocardial infarction in 4 US States between 1992 and 2001: clinical characteristics, quality of care, and outcomes. Circulation 2006 114 25 2806 2814 2-s2.0-33845900201 10.1161/CIRCULATIONAHA.106.611707 (Pubitemid 46018283)
18. Steiger V. S., Goy J.-J., Stauffer J.-C., Radovanovic D., Duvoisin N., Urban P., Bertel O., Erne P., Significant decrease in in-hospital mortality and major adverse cardiac events in Swiss STEMI patients between 2000 and December 2007. Swiss Medical Weekly 2009 139 31-32 453 457 2-s2.0-68549136707
19. Gupta M., Doobay A. V., Singh N., Anand S. S., Raja F., Mawji F., Kho J., Karavetian A., Yi Q., Yusuf S., Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects. Canadian Medical Association Journal 2002 166 6 717 722 2-s2.0-0036204494 (Pubitemid 34253120)
20. Yusuf P. S., Hawken S., Ôunpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 2004 364 9438 937 952 2-s2.0-4444382796 10.1016/S0140-6736(04)17018-9 (Pubitemid 39208455)
21. Khot U. N., Khot M. B., Bajzer C. T., Sapp S. K., Ohman E. M., Brener S. J., Ellis S. G., Lincoff A. M., Topol E. J., Prevalence of conventional risk factors in patients with coronary heart disease. Journal of the American Medical Association 2003 290 7 898 904 2-s2.0-0042697063 10.1001/jama.290.7.898 (Pubitemid 37430461)
22. Fox C. S., Evans J. C., Larson M. G., Kannel W. B., Levy D., Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 2004 110 5 522 527 2-s2.0-3543124216 10.1161/01.CIR.0000136993.34344.41 (Pubitemid 39031167)
23. Takii T., Yasuda S., Takahashi J., Ito K., Shiba N., Shirato K., Shimokawa H., Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI registry study. Circulation Journal 2010 74 1 93 100 2-s2.0-75149152485 10.1253/circj.CJ-09-0619
24. Parikh N. I., Gona P., Larson M. G., Fox C. S., Benjamin E. J., Murabito J. M., O'Donnell C. J., Vasan R. S., Levy D., Long-term trends in myocardial infarction incidence and case fatality in the national heart, lung, and blood institute's Framingham Heart Study. Circulation 2009 119 9 1203 1210 2-s2.0-63649155056 10.1161/CIRCULATIONAHA.108.825364
25. McGovern P. G., Jacobs D. R. Jr., Shahar E., Arnett D. K., Folsom A. R., Blackburn H., Luepker R. V., Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota Heart Survey. Circulation 2001 104 1 19 24 2-s2.0-0035800102 (Pubitemid 32623284)
26. Roger V. L., Jacobsen S. J., Weston S. A., Goraya T. Y., Killian J., Reeder G. S., Kottke T. E., Yawn B. P., Frye R. L., Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Annals of Internal Medicine 2002 136 5 341 348 2-s2.0-0037022801 (Pubitemid 34183992)
27. Floyd K. C., Yarzebski J., Spencer F. A., Lessard D., Dalen J. E., Alpert J. S., Gore J. M., Goldberg R. J., A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction Worcester Heart Attack Study. Circulation: Cardiovascular Quality and Outcomes 2009 2 2 88 95 2-s2.0-68849103312 10.1161/CIRCOUTCOMES.108.811828
28. Alpert J. S., Thygesen K., Antman E., Bassand J. P., Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology 2001 36 3 959 969 2-s2.0-0035282186
29. Gehani A. A., Al-Hinai A. T., Zubaid M., Almahmeed W., Hasani M. R., Yusufali A. H., Hassan M. O., Lewis B. S., Islam S., Rangarajan S., Yusuf S., Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East Study. European Journal of Preventive Cardiology 2014 21 4 400 410 10.1177/2047487312465525
30. Nallamothu B. K., Young J., Gurm H. S., Pickens G., Safavi K., Recent trends in hospital utilization for acute myocardial infarction and coronary revascularization in the United States. American Journal of Cardiology 2007 99 6 749 753 2-s2.0-33847796146 10.1016/j.amjcard.2006.10.029 (Pubitemid 46389372)
31. Hasdai D., Behar S., Wallentin L., Danchin N., Gitt A. K., Boersma E., Fioretti P. M., Simoons M. L., Battler A., A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin: the Euro Heart Survey of Acute Coronary Syndromes. European Heart Journal 2002 23 15 1190 1201 2-s2.0-0036701017 10.1053/euhj.2002.3193 (Pubitemid 35215245)
32. Fox K. A. A., Goodman S. G., Klein W., Brieger D., Steg G., Dabbous O., Avezum Á., Management of acute coronary syndromes. Variations in practice and outcome: findings from the Global Registry of Acute Coronary Events (GRACE). European Heart Journal 2002 23 15 1177 1189 2-s2.0-0036700407 10.1053/euhj.2001.3081 (Pubitemid 35215244)
33. Kolh P., Wijns W., Joint ESC/EACTS guidelines on myocardial revascularization. Journal of Cardiovascular Medicine 2011 12 4 264 267 2-s2.0-79953658565 10.2459/JCM.0b013e328344e647
34. Yusuf S., Zhao F., Mehta S. R., Chrolavicius S., Tognoni G., Fox K. K., Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. The New England Journal of Medicine 2001 345 7 494 502 2-s2.0-0035899289 10.1056/NEJMoa010746 (Pubitemid 32758501)
35. De Vita C., Fazzini P. F., Geraci E., Tavazzi L., Tognoni G., Vecchio C., Boeri R., D'Amico G., Loi U., Marubini E., Pagliaro L., Rovelli F., Franzosi M. G., Latini R., Maggioni A. P., Mauri F., Volpi A., Barlera S., Negri E., GISSI-3: effects of lisinopril and transdermal glyceryl binitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. The Lancet 1994 343 8906 1115 1122 2-s2.0-0028273258 (Pubitemid 24142031)
36. Collins R., Peto R., Flather M., Parish S., Sleight P., Conway M., Pipilis A., Baigent C., Barnett D., Boissel J.-P., Budaj A., Cairns J., Ceremuzynski L., Cohen A. F., De Backer G., Diaz R., Dienstl F., Dove P., Franzosi M.-G., ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. The Lancet 1995 345 8951 669 685 2-s2.0-0028932732 10.1016/S0140-6736(95)90865-X
37. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. The Lancet 1986 2 8498 57 66
38. Hjalmarson A., Herlitz J., Holmberg S., Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. European Heart Journal 1985 6 3 199 226 2-s2.0-0021839784 (Pubitemid 15063002)
39. Roberts R., Rogers W. J., Mueller H. S., Lambrew C. T., Diver D. J., Smith H. C., Willerson J. T., Knatterud G. L., Forman S., Passamani E., Zaret B. L., Wackers F. J. T., Braunwald E., Immediate versus deferred β -blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B study. Circulation 1991 83 2 422 437 2-s2.0-0026099412
40. Pfisterer M., Cox J. L., Granger C. B., Brener S. J., Naylor C. D., Califf R. M., Van De Werf F., Stebbins A. L., Lee K. L., Topol E. J., Armstrong P. W., Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Journal of the American College of Cardiology 1998 32 3 634 640 2-s2.0-0031667044 10.1016/S0735-1097(98)00279-4 (Pubitemid 28435246)
41. Harjai K. J., Stone G. W., Boura J., Grines L., Garcia E., Brodie B., Cox D., O'Neill W. W., Grines C., Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. American Journal of Cardiology 2003 91 6 655 660 2-s2.0-0037443761 10.1016/S0002-9149(02)03401-X (Pubitemid 36287453)
42. Carruthers K. F., Dabbous O. H., Flather M. D., Starkey I., Jacob A., MacLeod D., Fox K. A. A., Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE). Heart 2005 91 3 290 298 2-s2.0-14244251065 10.1136/hrt.2003. 031237 (Pubitemid 40299203)
43. Gehani A., Al Suwaidi J., Arafa S., Primary coronary angioplasty for ST-elevation myocardial infarction: first Nationwide Program in Qatar. Global Cardiology Science and Practice 2012 1 23 29
44. Fassa A.-A., Urban P., Radovanovic D., Duvoisin N., Gaspoz J.-M., Stauffer J.-C., Erne P., Temporal trends in treatment of ST segment elevation myocardial infarction in Switzerland from 1997 to 2005. Revue Medicale Suisse 2006 2 67 1393 1398 2-s2.0-33746649763 (Pubitemid 44503494)
45. Panduranga P., Sulaiman K., Al-Zakwani I., Zubaid M., Rashed W., Al-Mahmeed W., Al-Lawati J., Al-Motarreb A., Haitham A., Suwaidi J., Al-Habib K., Utilization and determinants of in-hospital cardiac catheterization in patients with acute coronary syndrome from the Middle East. Angiology 2010 61 8 744 750 2-s2.0-78049434145
46. Epstein A. J., Polsky D., Yang F., Yang L., Groeneveld P. W., Coronary revascularization trends in the united states, 2001-2008. Journal of the American Medical Association 2011 305 17 1769 1776 2-s2.0-79955624770 10.1001/jama.2011.551